115 related articles for article (PubMed ID: 29215949)
21. Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors.
King J; Ashkar R; Kesler K; Althouse SK; Hanna NH; Einhorn LH; Adra N
JAMA Oncol; 2024 Jan; 10(1):132-134. PubMed ID: 37943568
[TBL] [Abstract][Full Text] [Related]
22. Intratumoral Heterogeneity, Chemoresistance and Lymph Node Landing Zone Prognosis in Testicular Tumors Based on Histopathological Characteristics.
Singh Y; Barua SK; Singh VK; Trivedi S; Rajeev TP; Koti SR; Garg N
Ann Surg Oncol; 2024 May; 31(5):3544-3553. PubMed ID: 38381210
[TBL] [Abstract][Full Text] [Related]
23. Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Koyama J; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2023 Nov; 30(11):1044-1050. PubMed ID: 37522577
[TBL] [Abstract][Full Text] [Related]
24. Robotic-assisted retroperitoneal lymph node dissection for stage II testicular cancer.
McClintock G; Goolam AS; Perera D; Downey R; Leslie S; Grimison P; Woo H; Ferguson P; Ahmadi N
Asian J Urol; 2024 Jan; 11(1):121-127. PubMed ID: 38312811
[TBL] [Abstract][Full Text] [Related]
25. Re: Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes. World J Urol. 2023 Jul 28. doi: 10.1007/s00345-023-04536-3.
Ghoreifi A; Djaladat H
World J Urol; 2023 Nov; 41(11):3385-3386. PubMed ID: 37733090
[No Abstract] [Full Text] [Related]
26. Laparoscopic exploration in the management of retroperitoneal masses.
Shalhav AL; Chan SW; Bercowsky E; Elbahnassy AM; McDougall EM; Clayman RV
JSLS; 1999; 3(3):209-14. PubMed ID: 10527333
[TBL] [Abstract][Full Text] [Related]
27. Case of the Month from University of Melbourne, Australia: refractory chyle leak after retroperitoneal lymph node dissection with updated algorithm.
Homewood DC; O'Brien JS; Manning T; Kelly B; Chan P; Thomas B; Lawrentschuk N
BJU Int; 2023 Dec; 132(6):641-644. PubMed ID: 37789671
[No Abstract] [Full Text] [Related]
28. Lessons learned from 40 years of managing chylous ascites following RPLND.
Masterson TA; Cary C; Foster RS
Urol Oncol; 2021 Jan; 39(1):1-2. PubMed ID: 38571278
[No Abstract] [Full Text] [Related]
29. Surgical strategies for postchemotherapy testis cancer.
Ghodoussipour S; Daneshmand S
Transl Androl Urol; 2020 Jan; 9(Suppl 1):S74-S82. PubMed ID: 32055488
[TBL] [Abstract][Full Text] [Related]
30. Overview of Novel Biomarkers for Management of Postchemotherapy Residual Masses in Testicular Cancer.
Ding R; Li X; Liu Z
Eur Urol Focus; 2024 May; ():. PubMed ID: 38724341
[TBL] [Abstract][Full Text] [Related]
31. Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor.
Ghodoussipour S; Daneshmand S
Urol Clin North Am; 2019 Aug; 46(3):389-398. PubMed ID: 31277733
[TBL] [Abstract][Full Text] [Related]
32. Comparison of laparoscopic, robotic, and open retroperitoneal lymph node dissection for non-seminomatous germ cell tumor: a single-center retrospective cohort study.
Lin J; Hu Z; Huang S; Shen B; Wang S; Yu J; Wang P; Jin X
World J Urol; 2023 Jul; 41(7):1877-1883. PubMed ID: 37332060
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy and prognostic factors of CT-guided
Yan H; Luo M; Wang L; Qiu Z; Mo Z; Xiang Z; Zhang Y; Chen G; Zhong Z; Wang X; Gao F; Zhang F
Cancer Imaging; 2020 Apr; 20(1):25. PubMed ID: 32252826
[TBL] [Abstract][Full Text] [Related]
34. Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer.
Mittakanti HR; Porter JR
Transl Androl Urol; 2020 Jan; 9(Suppl 1):S66-S73. PubMed ID: 32055487
[TBL] [Abstract][Full Text] [Related]
35. Robot-assisted laparoscopic retroperitoneal lymph node dissection with concomitant inferior vena cava thrombectomy for metastatic mixed testicular germ cell cancer: a case report.
Zhang K; Zhu G; Liu X; Tian J; Gu Y; Zhai M; Yang L; Liu W; Li H; Martinez Portillo FJ
J Med Case Rep; 2019 Aug; 13(1):272. PubMed ID: 31451109
[TBL] [Abstract][Full Text] [Related]
36. Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
Overs C; Beauval JB; Mourey L; Rischmann P; Soulié M; Roumiguié M; Doumerc N
World J Urol; 2018 Apr; 36(4):655-661. PubMed ID: 29353314
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
[TBL] [Abstract][Full Text] [Related]
39. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
[TBL] [Abstract][Full Text] [Related]
40. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
